Gujarat Kidney and Super Speciality – IPO
Gujarat Kidney and Super Speciality – IPO Details
| IPO Date | December 22, 2025 to December 24, 2025 |
| Listing Date | December 30, 2025 |
| Face Value | ₹ 2 / Share |
| Price Band | ₹ 108 to ₹ 114 / Share |
| Lot Size | 128 Shares |
| Total Issue Size | 2,20,00,000 shares (Aggregating up to ₹250.80 Cr) |
| Fresh Issue | |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 5,68,43,250 shares |
| Share holding post issue | 7,88,43,250 shares |
| Market Maker portion |
Gujarat Kidney and Super Speciality Timeline (Tentative Schedule)
Gujarat Kidney and Super Speciality IPO opens on December 22, 2025, and closes on December 24, 2025.
| IPO Open Date | December 22, 2025 |
| IPO Close Date | December 24, 2025 |
| Basis of Allotment | December 26, 2025 |
| Initiation of Refunds | December 29, 2025 |
| Credit of Shares to Demat | December 29, 2025 |
| Listing Date | December 30, 2025 |
| Cut-off time for UPI mandate confirmation | December 24, 2025 |
Gujarat Kidney and Super Speciality IPO Lot Size
Investors can bid for a minimum of 128 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 128 | Rs.14,592 |
| Retail (Max) | 13 | 1,664 | Rs.189,696 |
| S-HNI (Min) | 14 | 1,792 | Rs.204,288 |
| S-HNI (Max) | 68 | 8,704 | Rs.992,256 |
| B-HNI (Min) | 69 | 8,832 | Rs.1,006,848 |
| HNI (Min) |
Gujarat Kidney and Super Speciality IPO Promoter Holding
| Share Holding Pre Issue | 99.10% |
| Share Holding Post Issue | 71.45% |
Gujarat Kidney and Super Speciality IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not less than 75% |
|
| NII (HNI) Shares Offered | Not more than 15% |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not more than 10% |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
Gujarat Kidney and Super Speciality IPO Anchor Investors Details
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
About Gujarat Kidney and Super Speciality
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specialises in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Services:
- Secondary Care Services: General and surgical treatments.
- Tertiary Care Services: Super speciality surgical procedures.
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.
Competitive Strengths:
- Pre-eminence in renal sciences, with established sub-superspecialities in urology.
- Asset light business model with focus in central region of Gujarat.
- Ability to attract, retain skilled and experienced quality medical professionals.
- Track record of operating and financial performance and growth.
Key Performance Indicator
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 36.61% |
| ROCE | 37.65% |
| Debt/Equity | 0.15 |
| RoNW | 36.61% |
| P/BV | 22.62 |
| PAT Margin (%) | 23.61% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.85 | 2.74 |
| P/E (x) | 61.62 | 41.59 |
Note:
- The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
- The Pre IPO EPS is calculated based on Pre-IPO shareholding as of the date of RHP and the latest FY earnings as of March 31, 2025, which are available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of June 30, 2025, which are available in RHP.
Objects of the Issue (Gujarat Kidney and Super Speciality IPO Objectives)
Gujarat Kidney and Super Speciality Contact Details
Gujarat Kidney & Super Speciality Limited Plot No. 1, City Sarve No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara, Gujarat, 390020 Phone: +91 265 298 4800 Email: [email protected] Website: http://www.gujaratsuperspecialityhospital.com/ |
Gujarat Kidney and Super Speciality IPO Registrar
MUFG Intime India Pvt. Ltd. Phone: +91-22-4918 6270 Email: [email protected] Website: https://linkintime.co.in/Initial_Offer/public-issues.html |